- Home
- NKTR vs SBI Comparison
NKTR vs SBI Comparison
Compare NKTR & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- SBI
- Stock Information
- Founded
- NKTR 1990
- SBI 1992
- Country
- NKTR United States
- SBI United States
- Employees
- NKTR N/A
- SBI N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- SBI Finance/Investors Services
- Sector
- NKTR Health Care
- SBI Finance
- Exchange
- NKTR Nasdaq
- SBI Nasdaq
- Market Cap
- NKTR 108.3M
- SBI 104.9M
- IPO Year
- NKTR 1994
- SBI N/A
- Fundamental
- Price
- NKTR $24.48
- SBI $7.66
- Analyst Decision
- NKTR Strong Buy
- SBI
- Analyst Count
- NKTR 6
- SBI 0
- Target Price
- NKTR $77.50
- SBI N/A
- AVG Volume (30 Days)
- NKTR 4.6M
- SBI 39.5K
- Earning Date
- NKTR 08-07-2025
- SBI 01-01-0001
- Dividend Yield
- NKTR N/A
- SBI 4.52%
- EPS Growth
- NKTR N/A
- SBI N/A
- EPS
- NKTR N/A
- SBI N/A
- Revenue
- NKTR $87,248,000.00
- SBI N/A
- Revenue This Year
- NKTR N/A
- SBI N/A
- Revenue Next Year
- NKTR N/A
- SBI N/A
- P/E Ratio
- NKTR N/A
- SBI N/A
- Revenue Growth
- NKTR N/A
- SBI N/A
- 52 Week Low
- NKTR $6.48
- SBI $6.96
- 52 Week High
- NKTR $37.38
- SBI $8.00
- Technical
- Relative Strength Index (RSI)
- NKTR 68.00
- SBI 70.87
- Support Level
- NKTR $8.27
- SBI $7.40
- Resistance Level
- NKTR $26.59
- SBI $7.52
- Average True Range (ATR)
- NKTR 3.71
- SBI 0.05
- MACD
- NKTR 1.18
- SBI 0.02
- Stochastic Oscillator
- NKTR 57.06
- SBI 100.00
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About SBI Western Asset Intermediate Muni Fund Inc
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.